Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 10,682,000 | 10,863,000 | 11,456,000 | 13,138,000 | 10,742,000 |
| Cost of Goods | 3,268,000 | 3,079,000 | 3,734,000 | 3,831,000 | 3,250,000 |
| Gross Profit | 7,414,000 | 7,784,000 | 7,722,000 | 9,307,000 | 7,492,000 |
| Operating Expenses | 5,252,000 | 4,963,000 | 5,355,000 | 4,660,000 | 5,216,000 |
| Operating Income | 2,162,000 | 2,821,000 | 2,367,000 | 4,647,000 | 2,276,000 |
| Interest Expense | 202,000 | 168,000 | 180,000 | 103,000 | 101,000 |
| Other Income | -178,000 | -197,000 | 1,888,000 | -1,871,000 | -820,000 |
| Pre-tax Income | 1,782,000 | 2,456,000 | 4,075,000 | 2,673,000 | 1,355,000 |
| Income Tax | 271,000 | 459,000 | 910,000 | 601,000 | 163,000 |
| Net Income Continuous | 1,447,000 | 2,009,000 | 3,168,000 | 2,079,000 | 1,220,000 |
| Minority Interests | -12,000 | -14,000 | -57,000 | -3,000 | -45,000 |
| Net Income | $1,435,000 | $1,995,000 | $3,111,000 | $2,076,000 | $1,175,000 |
| EPS Basic Total Ops | 1.15 | 1.60 | 1.16 | 1.66 | 0.94 |
| EPS Basic Continuous Ops | 1.15 | 1.60 | 1.16 | 1.66 | 0.94 |
| EPS Diluted Total Ops | 1.15 | 1.60 | 1.16 | 1.66 | 0.94 |
| EPS Diluted Continuous Ops | 1.15 | 1.60 | 1.16 | 1.66 | 0.94 |
| EBITDA(a) | $2,530,000 | $3,113,000 | $4,938,000 | $3,236,000 | $1,917,000 |